Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG35950

JAG2 Knockout CaSki Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Squamous cell carcinoma

The JAG2 Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population that disrupts JAG2 expression in the Ca Ski cervical carcinoma line. This model enables loss-of-function studies of Jagged2, a Notch ligand that activates NOTCH1?C4 receptors upon cell contact, leading to NICD release and transcriptional regulation of targets such as Hes1. Ca Ski cells are HPV-16 positive and widely used for cervical cancer research. Applications include western blotting for JAG2 and NICD, RT-qPCR of Notch target genes, reporter assays, and drug screening to explore Notch pathway roles in cell differentiation, EMT, and oncogenesis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    CaSki

    Sex of Donor

    Female

    Age

    40 years

    Derived From Site

    Metastatic; Small intestine

    Gene Name

    JAG2

    Gene Identifier

    NCBI Gene ID 3714

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

This product is a CRISPR/Cas9-edited polyclonal JAG2 knockout cell population derived from the Ca Ski human cervical carcinoma cell line. The JAG2 Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population designed to disrupt expression of the JAG2 gene in the Ca Ski host cell line. This knockout model provides a powerful tool for investigating Jagged2-dependent signaling in a well-characterized cervical cancer background.

Ca Ski cells are a human cervical epidermoid carcinoma line that is positive for human papillomavirus type 16 (HPV-16). These epithelial cells are widely used as a model for cervical cancer and HPV-mediated oncogenesis, offering a relevant context for studying molecular mechanisms of tumorigenesis, viral integration, and host-virus interactions.

JAG2 encodes Jagged2, a single-pass transmembrane ligand for Notch receptors (NOTCH1?C4). Upon cell-cell contact, Jagged2 activates Notch signaling, triggering ADAM protease-mediated cleavage followed by ??-secretase-dependent release of the Notch intracellular domain (NICD). NICD translocates to the nucleus, where it forms a complex with the CSL transcription factor and coactivators to regulate target gene expression. Downstream transcriptional targets include the Hes and Hey families, Myc, and p21. Notch signaling is modulated by glycosyltransferases such as Lunatic Fringe, which modify receptor sensitivity to ligands. Upstream, JAG2 expression is regulated by transcription factors including E2F and NF-??B, and by cytokines such as TGF-??. The Jagged2-Notch pathway is central to cell fate decisions, epithelial-to-mesenchymal transition, and stem cell maintenance.

In Ca Ski cells, which harbor integrated HPV-16 genomes and constitutively express viral oncogenes E6 and E7, JAG2 knockout provides a precise genetic background to dissect the interplay between Notch signaling and HPV-driven transformation. The polyclonal nature preserves heterogeneity while eliminating Jagged2-dependent signaling, enabling studies of how Notch pathway alterations influence cervical cancer cell proliferation, apoptosis, migration, and invasion. This model is especially valuable for examining crosstalk between Notch and other oncogenic pathways in a cervical carcinoma setting.

Researchers can employ these cells in a variety of functional assays, including western blotting for JAG2 and NICD, RT-qPCR analysis of Notch target genes, reporter assays using Notch-responsive luciferase constructs, immunofluorescence for Jagged2 localization, and flow cytometric assessment of Notch receptor activation. Additional applications include apoptosis assays, migration and invasion studies, and drug screening to identify Notch pathway modulators. The JAG2 knockout Ca Ski cells are suitable for investigating cervical cancer biology, Notch-mediated cell differentiation, and developmental signaling. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)